World Health Organization (WHO) is recommending widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine among children in sub-Saharan Africa and in other regions with moderate to high P. falciparum malaria transmission. The recommendation is based on results from an ongoing pilot programme in Ghana, Kenya & Malawi that has reached more than 800 000 children since 2019.
The vaccine is developed by British drugmaker GlaxoSmithKline (GSK). Many vaccines exist against viruses and bacteria but this was the first time that the WHO recommended broad use of a vaccine against a human parasite. The vaccine acts against Plasmodium falciparum, one of five parasite species and the most deadly. The symptoms of malaria are fever, headaches, and muscle pain, then cycles of chills, fever, and sweating.
Important takeaways for all competitive exams:
The Securities and Exchange Board of India (SEBI) has operationalized the Past Risk and Return…
Have you wondered if there are places on Earth where it never snows? Yes, such…
The Employees Provident Fund Organization is set to launch the new digital platform called the…
The Reserve Bank of India had introduced the revised guidelines for loan restructuring for the…
The India and Sri Lanka successfully conducted the fourth edition of the bilateral diving exercise…
Today, digital payments have become a daily habit in India. From buying vegetables to paying…